Gut micro-organism in bees unfold antibiotic-resistant genes to each other


 Gut micro-organism in bees unfold antibiotic-resistant genes to each other 

In the study, scientists investigated gut bacteria in honey bees to explore the query, "What happens to 
intestine microorganism when they're exposed to antibiotics over a long time period?" even as honey bees have a less difficult microbial network of their guts in comparison to humans, they also have functions in common place.

There may be an vital similarity between honey bee and human gut micro-organism, in that a few microorganism are in symbiosis with the host—those are essential for host fitness". The micro-organism that was investigated is symbiotic for the honey bee, and acts as motive to spread antibiotic-resistant genes in host. 
In their observation, researchers focused on microbes that are resistant to tetracycline, further to use in human therapy, tetracycline is an antibiotic that has been widely used for many years to promote growth in animals—regularly in chicken, farm animals and pig farming. It is also commonly sprayed on flowers, such as apple and pear trees, to make disease resistant which include fire blight that can devastate crops.  In U.S., tetracycline has been used even on natural farms. In Norway, rules on antibiotic use in farming of any type are lots stricter. 
Scientists compared the antibiotic-resistant genes in honey bee populations of Arizona with Norway honey bee populations and saw unexpected geographic differences. 

In the bees from Arizona, they saw that even though they've now not been in touch with tetracycline for many years, the resistance genes are nevertheless there. But in the Norwegian population, they found a few antibiotic-resistant genes. However, they concluded that if there are greater resistance genes inside the environment, greater transfer takes place. Additionally, if the bees are exposed to tetracycline of their surroundings, they will need to get and keep the resistance genes.



For more details go through the link: https://bacteriology.infectiousconferences.com/

Comments

Post a Comment

Popular posts from this blog

Neisseria gonorrhoeae: Combating a Multidrug-Resistant Organism

Image
Neisseria gonorrhoeae: Combating a Multidrug-Resistant Organism: The worldwide spread of anti-toxin resistant sexually transmitted diseases (STD) has received increased consideration in the course of recent years from health institutes including the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC). In this post we will give a background marked by multidrug-safe Neisseria gonorrhoeae taken after by a depiction of the test techniques clinical labs are utilizing to decide the antimicrobial susceptibilities of N. gonorrhoeae isolates. About Gonorrhea Gonorrhea is a worldwide widespread disease caused by N. gonorrhoeae, a Gram-negative bacterium. As per CDC, roughly 470,000 new gonorrheal diseases were accounted for. Notwithstanding, on the grounds that numerous cases are asymptomatic, and consequently unreported, it is evaluated that there are roughly 820,000 new cases every year. Furthermore, it is assessed that 246,000 of these cases conv
Read more

The antibiotic that is active against drug-resistant tuberculosis:

Image
The antibiotic that is active against drug-resistant tuberculosis:  A naturally occurring antibiotic called kanglemycin A is effective against Mycobacterium tuberculosis, the bacteria that cause tuberculosis, even in drug-resistant strains, according to an international team of researchers who used chemistry, molecular biology, microbiology, and X-ray crystallography to show how the compound maintains its activity.  The compound, kanglemycin A, is related to the antibiotic rifampicin, according to Katsuhiko Murakami, professor of biochemistry and molecular biology at Penn State and one of leaders of the project. "Rifampicin is already part of the cocktail of antibiotics used to treat tuberculosis, but many strains of the tuberculosis-causing bacteria have developed resistance to it," Murakami said. "Tuberculosis is the leading cause of death by infectious disease worldwide," said Murakami. "Development of rifampicin resistance in M. tuberculosis has m
Read more

A new and promising class of chemical compounds has major potential for treating Zika virus and respiratory syncytial virus, or RSV, according to a new study by University of Alberta scientists. The next step is to develop a drug.

Image
A new and promising class of chemical compounds has major potential for treating Zika virus and respiratory syncytial virus, or RSV, according to a new study by University of Alberta scientists. The next step is to develop a drug... Another and promising class of synthetic mixes has the noteworthy potential for treating Zika disease and respiratory syncytial infection, or RSV, according to another examination by University of Alberta scientists. The accompanying stage is to develop a medication. "This is both a wonderful scientific discovery and something that can possibly emphatically influence worldwide wellbeing as well as the economy of Canada," said Fred West, professor in the Department of Chemistry who led the new discovery along with David Marchant. The compound is alike isatisine A which is an antiviral compound usually found in traditional Chinese herbal medicine. Hobman is a professor of cell biology and a specialist in the Zika virus, a pathogen that can
Read more